Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) reported Other Non-Current Assets of $11000.0 for Q4 2025, down 56.0% on a YoY basis from $25000.0 in Q4 2024, and down 97.8% sequentially from $500000.0 in Q3 2025.
Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Other Non-Current Assets data on file, last reported at $11000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 56.0% year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $11000.0 (down 56.0% YoY), and the FY2025 full-year result was $28000.0, up 12.0% from the prior year.
- Other Non-Current Assets declined to $11000.0 in Q4 2025, from $500000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $984000.0 in Q2 2021 to a low of $9000.0 in Q1 2021.
- A 5-year average of $188052.6 and a median of $97000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets jumped 10833.33% in 2021 and tumbled 86.28% in 2022, its largest moves.
- Tracing BNTC's Other Non-Current Assets over 5 years: stood at $161000.0 in 2021, then dropped by 27.95% to $116000.0 in 2022, then slumped by 30.17% to $81000.0 in 2023, then plunged by 69.14% to $25000.0 in 2024, then plunged by 56.0% to $11000.0 in 2025.
- Business Quant data shows BNTC's Other Non-Current Assets at $11000.0 in Q4 2025, $500000.0 in Q3 2025, and $28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 85,000.00 |
| Jun 30, 2023 | 97,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Dec 31, 2021 | 161,000.00 |
| Sep 30, 2021 | 811,000.00 |
| Jun 30, 2021 | 984,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 562,000.00 |